Clinical Trial Update: Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether amoxicillin given around intensive periodontal therapy reduces bacteremia and inflammatory biomarkers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Periodontitis

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: Universidad El Bosque, Bogotá | Conditions: Chronic Periodontitis, Bacteremia | Phase 2 | Status: UNKNOWN